Senior Vice President of $MCHP sells 4,400 shares in insider sale

Recently, Joseph R II Krawczyk, the Senior Vice President of $MCHP, made a significant transaction by selling 4,400 shares of the company on 02-12-2026 for an estimated $345,743, as reported in a recent SEC filing. This sale accounted for around 25.6% of his shares in this class of stock, leaving him with 12,781 shares of this particular $MCHP stock.

Looking at $MCHP’s insider trading activity over the past 6 months, executives within the company have engaged in trading on the open market 8 times. These activities included selling transactions but no purchases. For instance, company President, CEO, and Chair of the Board, Steve Sanghi, conducted 2 sales of 117,323 shares, amounting to approximately $9,425,696. Similarly, Matthew B Bunker, Senior Vice President of Operations, sold 10,000 shares for $783,700, and James Eric Bjornholt, Senior Vice President, and CFO, completed 3 sales of 11,648 shares valuing at $721,769. Matthew W Chapman also sold 10,000 shares, estimated at $682,550.

Hedge fund activity around $MCHP has seen 473 institutional investors adding shares to their portfolios and 664 reducing their positions in the most recent quarter. Notable movements include UBS AM, a distinct unit of UBS Asset Management Americas LLC, removing 8,688,217 shares, a decrease of 74.9% during Q4 2025, corresponding to approximately $553,613,187. Conversely, Barclays PLC added 5,590,210 shares to their portfolio, an increase of 66.5% in Q4 2025, totaling around $356,208,181. Additionally, Invesco Ltd. removed 4,144,979 shares (-22.5%) in Q3 2025, amounting to approximately $266,190,551, while Norges Bank added 3,703,281 shares (+55.1%) in Q4 2025, valued at $235,973,065.

When it comes to $MCHP’s financials, the company reported revenues of $1.2B in Q3 2026, reflecting a 15.59% increase compared to the same period in the previous year. Analysts have been closely monitoring $MCHP, with 9 firms issuing buy ratings on the stock and none recommending sell actions. Recent analyst ratings have seen Cantor Fitzgerald, Piper Sandler, Mizuho, and others issuing buy ratings or favorable outlooks on the company’s stock.

A glance at recent price targets set by analysts reveals a median target of $90.0 for $MCHP. Of the 17 analysts providing price targets in the last 6 months, various figures have been cited, including $80.0, $69.0, $91.0, $100.0, $95.0, $84.0, and $115.0, showcasing diverse perspectives on the company’s future performance in the market. Investing decisions should be made cautiously, considering individual circumstances and consulting financial experts if necessary.